Sunday 22 November 2026 Live: Iran war Stories Browse Wire Subscribe
Faultline Journal — home

AmericasDevelopingDay 2

Bayer Roundup cancer settlement approval

Bayer's share price has fallen 46% since its $63bn Monsanto purchase in 2018, and it settled much of the Roundup litigation for $10.9bn in 2020.

Updated 17:15 UTC, 21 November 2026 · 3 reports from 3 outlets · 2 confirmed · 13 one-source

Top reportUS court greenlights Bayer’s $7.25 bn Roundup cancer dealRT · State media ·

Image from RT: US court greenlights Bayer’s $7.25 bn Roundup cancer deal

Image: RT

Read it your way

Loading the summary…

Written by AI only from the receipts on this page; each number links to the claim that line rests on.

What changed

Last 48 hours, newest first (times UTC)

  1. Where it stands Bayer's share price has fallen 46% since its $63bn Monsanto purchase in 2018, and it settled much of the Roundup litigation for $10.9bn in 2020. 21 hrs ago
9 earlier changes
  1. Story opened A US judge has approved Bayer's $7.25bn settlement of claims that its Roundup weedkiller causes cancer. 21 hrs ago

How it’s being told

One card per media bloc, with each outlet’s framing written from its own headlines.

Russian state media

RTState media

  • RT foregrounds the court's approval of Bayer's '$7.25 bn Roundup cancer deal' and the WHO's 'probably carcinogenic' classification, centring the litigation's legal and health stakes while noting the.

European media

Financial TimesPrivateThe GuardianNon-profit

  • The Financial Times centres the US judge's approval of Bayer's '$7.25bn settlement over cancer cases', foregrounding the legal outcome and sum while omitting the state line's context on.
  • The Guardian centres the judge's approval of a '$7.25bn Bayer payout' and the litigation history behind it, foregrounding Bayer's CEO calling the approval a 'decisive milestone' while noting.

In their words

What the people at the centre of this story said, word for word, with the article each quote appeared in.

The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation

Bill AndersonBayer CEOThe GuardianReceipt

Receipts

Every claim with the verbatim sentence it came from. Tap a claim to see its sources.

Confirmed 2

Reported by at least two independent outlets, or by the actor itself.

Bayer settled much of the Roundup litigation for $10.9bn in 2020. Confirmed by 2RT, The Guardian · #
Bayer's share price has fallen 46% since it bought Monsanto for $63bn in 2018. Confirmed by 2RT, The Guardian · #

One source 13

Only one outlet so far. Shown, never hidden — treat with care.

The World Health Organization's cancer research agency classified glyphosate as 'probably carcinogenic' in 2015. One source: RTRT · #
Around 200 cases remain pending in federal courts outside the settlement. One source: RTRT · #
Bayer set aside around $16 billion for related legal costs. One source: RTRT · #
Bayer has spent at least $14 billion on Roundup litigation. One source: RTRT · #
The US Supreme Court restricted lawsuits under state laws requiring additional cancer warnings in June. One source: RTRT · #
Bayer reached a preliminary settlement in February after years of litigation. One source: RTRT · #
The US supreme court overturned a $1.25m jury award for Missouri man John Durnell, who blamed Roundup exposure for his non-Hodgkin lymphoma. One source: The GuardianThe Guardian · #
Bayer CEO Bill Anderson called the court's final approval a decisive milestone in the company's strategy to mitigate Roundup litigation risks. One source: The GuardianThe Guardian · #
Bayer announced the Roundup settlement in February. One source: The GuardianThe Guardian · #
Bayer faced approximately 65,000 claims from people who said they developed cancer after using Roundup. One source: The GuardianThe Guardian · #
Judge Timothy Boyer found the Roundup settlement fair, reasonable and adequate. One source: The GuardianThe Guardian · #
A Missouri judge approved Bayer's $7.25bn settlement of lawsuits alleging Roundup causes cancer on Friday. One source: The GuardianThe Guardian · #
A US judge approved Bayer's $7.25bn settlement over cancer cases. One source: Financial TimesFinancial Times · #

Ask about this story

Line, our AI correspondent, answers only from the receipts on this page. Every sentence links to the claim behind it.

All sources

3 reports from 3 outlets — with who owns each outlet and who pays for it.

RT State media

RussiaOwner: ANO TV-NovostiPaid by: Russian federal budget

Financial Times Private

United KingdomOwner: Nikkei Inc.Paid by: subscriptions + advertising

The Guardian Non-profit

United KingdomOwner: Guardian Media Group, owned by the Scott Trust LimitedPaid by: reader contributions + subscriptions + advertising; Scott Trust endowment

Not covered yet by

Al JazeeraAssociated PressBBCCGTNCNADWEuronewsForeign PolicyFox NewsFrance 24NPRReutersSky NewsSouth China Morning PostSputnikTASSTRT WorldThe New York TimesThe Times of IndiaWION

Outlets we monitor that have not reported this story. Silence can be signal.

From the Faultline desk

Our analysis pieces on this story.

Read the AI explainer

2 confirmed · 13 one-source3 outletsUpdated